Neuland Laboratories Proporción de pago

¿Qué es el Proporción de pago de Neuland Laboratories?

El Proporción de pago de Neuland Laboratories Limited es 71.63%

¿Cuál es la definición de Proporción de pago?



El ratio de pago es la fracción de las ganancias pagadas en dividendos a los accionistas.

The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.

Proporción de pago de compañías en Sector Health Care en BSE en comparadas con Neuland Laboratories

¿Qué hace Neuland Laboratories?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Empresas con proporción de pago similar a Neuland Laboratories